MOBILEYE GLOBAL INC-A (MBLY) Stock Fundamental Analysis

NASDAQ:MBLY • US60741F1049

8.46 USD
-0.29 (-3.31%)
At close: Feb 27, 2026
8.43 USD
-0.03 (-0.35%)
After Hours: 2/27/2026, 8:16:53 PM
Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to MBLY. MBLY was compared to 41 industry peers in the Automobile Components industry. MBLY has a great financial health rating, but its profitability evaluates not so good. MBLY shows excellent growth, but is valued quite expensive already.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

  • MBLY had positive earnings in the past year.
  • In the past year MBLY had a positive cash flow from operations.
  • In the past 5 years MBLY always reported negative net income.
  • In the past 5 years MBLY always reported a positive cash flow from operatings.
MBLY Yearly Net Income VS EBIT VS OCF VS FCFMBLY Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 2025 0 -1B -2B -3B

1.2 Ratios

  • With a Return On Assets value of -3.14%, MBLY is not doing good in the industry: 60.98% of the companies in the same industry are doing better.
  • Looking at the Return On Equity, with a value of -3.30%, MBLY is in line with its industry, outperforming 48.78% of the companies in the same industry.
Industry RankSector Rank
ROA -3.14%
ROE -3.3%
ROIC N/A
ROA(3y)-9.29%
ROA(5y)-5.77%
ROE(3y)-9.68%
ROE(5y)-6.01%
ROIC(3y)N/A
ROIC(5y)N/A
MBLY Yearly ROA, ROE, ROICMBLY Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 2025 -5 -10 -15 -20 -25

1.3 Margins

  • Looking at the Gross Margin, with a value of 47.73%, MBLY belongs to the top of the industry, outperforming 95.12% of the companies in the same industry.
  • In the last couple of years the Gross Margin of MBLY has grown nicely.
  • MBLY does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 47.73%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.09%
GM growth 5Y4.19%
MBLY Yearly Profit, Operating, Gross MarginsMBLY Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 2025 0 50 -50 -100 -150

8

2. Health

2.1 Basic Checks

  • MBLY does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for MBLY has been increased compared to 1 year ago.
  • Compared to 5 years ago, MBLY has more shares outstanding
  • MBLY has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
MBLY Yearly Shares OutstandingMBLY Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M
MBLY Yearly Total Debt VS Total AssetsMBLY Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 2025 5B 10B 15B

2.2 Solvency

  • An Altman-Z score of 6.83 indicates that MBLY is not in any danger for bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 6.83, MBLY belongs to the top of the industry, outperforming 87.80% of the companies in the same industry.
  • There is no outstanding debt for MBLY. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 6.83
ROIC/WACCN/A
WACC8.58%
MBLY Yearly LT Debt VS Equity VS FCFMBLY Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B

2.3 Liquidity

  • MBLY has a Current Ratio of 6.10. This indicates that MBLY is financially healthy and has no problem in meeting its short term obligations.
  • The Current ratio of MBLY (6.10) is better than 92.68% of its industry peers.
  • A Quick Ratio of 5.30 indicates that MBLY has no problem at all paying its short term obligations.
  • MBLY has a better Quick ratio (5.30) than 92.68% of its industry peers.
Industry RankSector Rank
Current Ratio 6.1
Quick Ratio 5.3
MBLY Yearly Current Assets VS Current LiabilitesMBLY Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

7

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 44.00% over the past year.
  • Looking at the last year, MBLY shows a quite strong growth in Revenue. The Revenue has grown by 14.51% in the last year.
  • MBLY shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 14.39% yearly.
EPS 1Y (TTM)44%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-53.85%
Revenue 1Y (TTM)14.51%
Revenue growth 3Y0.44%
Revenue growth 5Y14.39%
Sales Q2Q%-8.98%

3.2 Future

  • MBLY is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 30.09% yearly.
  • The Revenue is expected to grow by 27.59% on average over the next years. This is a very strong growth
EPS Next Y-23.59%
EPS Next 2Y5.18%
EPS Next 3Y26.04%
EPS Next 5Y30.09%
Revenue Next Year3.6%
Revenue Next 2Y8.69%
Revenue Next 3Y14.87%
Revenue Next 5Y27.59%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
MBLY Yearly Revenue VS EstimatesMBLY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2B 4B 6B
MBLY Yearly EPS VS EstimatesMBLY Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 2030 0.2 0.4 0.6 0.8 1

2

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 23.50, the valuation of MBLY can be described as rather expensive.
  • The rest of the industry has a similar Price/Earnings ratio as MBLY.
  • MBLY's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 27.07.
  • MBLY is valuated quite expensively with a Price/Forward Earnings ratio of 30.75.
  • 65.85% of the companies in the same industry are cheaper than MBLY, based on the Price/Forward Earnings ratio.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 28.05, MBLY is valued at the same level.
Industry RankSector Rank
PE 23.5
Fwd PE 30.75
MBLY Price Earnings VS Forward Price EarningsMBLY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • MBLY's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. MBLY is more expensive than 63.41% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, MBLY is valued a bit cheaper than 63.41% of the companies in the same industry.
Industry RankSector Rank
P/FCF 13.59
EV/EBITDA 48.06
MBLY Per share dataMBLY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10

4.3 Compensation for Growth

  • A more expensive valuation may be justified as MBLY's earnings are expected to grow with 26.04% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y5.18%
EPS Next 3Y26.04%

0

5. Dividend

5.1 Amount

  • MBLY does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

MOBILEYE GLOBAL INC-A

NASDAQ:MBLY (2/27/2026, 8:16:53 PM)

After market: 8.43 -0.03 (-0.35%)

8.46

-0.29 (-3.31%)

Chartmill FA Rating
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobile Components
Earnings (Last)01-22
Earnings (Next)04-22
Inst Owners75.91%
Inst Owner Change-7.46%
Ins Owners2.17%
Ins Owner Change72.39%
Market Cap7.11B
Revenue(TTM)1.89B
Net Income(TTM)-392.00M
Analysts73.14
Price Target15.83 (87.12%)
Short Float %17.01%
Short Ratio3.66
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.29%
Min EPS beat(2)-2.19%
Max EPS beat(2)2.78%
EPS beat(4)3
Avg EPS beat(4)6.98%
Min EPS beat(4)-2.19%
Max EPS beat(4)23.2%
EPS beat(8)6
Avg EPS beat(8)6.68%
EPS beat(12)10
Avg EPS beat(12)10.65%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)1.91%
Min Revenue beat(2)1.14%
Max Revenue beat(2)2.68%
Revenue beat(4)3
Avg Revenue beat(4)1.41%
Min Revenue beat(4)-1.33%
Max Revenue beat(4)3.17%
Revenue beat(8)7
Avg Revenue beat(8)1.29%
Revenue beat(12)7
Avg Revenue beat(12)0.32%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-18.86%
PT rev (3m)-19.75%
EPS NQ rev (1m)-1.28%
EPS NQ rev (3m)18.89%
EPS NY rev (1m)-31.01%
EPS NY rev (3m)-35.4%
Revenue NQ rev (1m)1.02%
Revenue NQ rev (3m)12.36%
Revenue NY rev (1m)-1.24%
Revenue NY rev (3m)-3.31%
Valuation
Industry RankSector Rank
PE 23.5
Fwd PE 30.75
P/S 3.75
P/FCF 13.59
P/OCF 11.81
P/B 0.6
P/tB 2.83
EV/EBITDA 48.06
EPS(TTM)0.36
EY4.26%
EPS(NY)0.28
Fwd EY3.25%
FCF(TTM)0.62
FCFY7.36%
OCF(TTM)0.72
OCFY8.47%
SpS2.25
BVpS14.14
TBVpS2.99
PEG (NY)N/A
PEG (5Y)N/A
Graham Number10.7
Profitability
Industry RankSector Rank
ROA -3.14%
ROE -3.3%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 47.73%
FCFM 27.61%
ROA(3y)-9.29%
ROA(5y)-5.77%
ROE(3y)-9.68%
ROE(5y)-6.01%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.09%
GM growth 5Y4.19%
F-Score7
Asset Turnover0.15
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 15.28%
Cap/Sales 4.17%
Interest Coverage N/A
Cash Conversion 781.82%
Profit Quality N/A
Current Ratio 6.1
Quick Ratio 5.3
Altman-Z 6.83
F-Score7
WACC8.58%
ROIC/WACCN/A
Cap/Depr(3y)16.8%
Cap/Depr(5y)19.43%
Cap/Sales(3y)4.59%
Cap/Sales(5y)6.01%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)44%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-53.85%
EPS Next Y-23.59%
EPS Next 2Y5.18%
EPS Next 3Y26.04%
EPS Next 5Y30.09%
Revenue 1Y (TTM)14.51%
Revenue growth 3Y0.44%
Revenue growth 5Y14.39%
Sales Q2Q%-8.98%
Revenue Next Year3.6%
Revenue Next 2Y8.69%
Revenue Next 3Y14.87%
Revenue Next 5Y27.59%
EBIT growth 1Y16.98%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year27.99%
EBIT Next 3Y41.27%
EBIT Next 5Y38.51%
FCF growth 1Y63.95%
FCF growth 3Y6.33%
FCF growth 5Y23.78%
OCF growth 1Y50.5%
OCF growth 3Y3.31%
OCF growth 5Y17.31%

MOBILEYE GLOBAL INC-A / MBLY FAQ

What is the fundamental rating for MBLY stock?

ChartMill assigns a fundamental rating of 5 / 10 to MBLY.


What is the valuation status for MBLY stock?

ChartMill assigns a valuation rating of 2 / 10 to MOBILEYE GLOBAL INC-A (MBLY). This can be considered as Overvalued.


Can you provide the profitability details for MOBILEYE GLOBAL INC-A?

MOBILEYE GLOBAL INC-A (MBLY) has a profitability rating of 3 / 10.


How financially healthy is MOBILEYE GLOBAL INC-A?

The financial health rating of MOBILEYE GLOBAL INC-A (MBLY) is 8 / 10.


What is the expected EPS growth for MOBILEYE GLOBAL INC-A (MBLY) stock?

The Earnings per Share (EPS) of MOBILEYE GLOBAL INC-A (MBLY) is expected to decline by -23.59% in the next year.